ACC AHA guidelines classification scheme: Difference between revisions
No edit summary |
|||
Line 7: | Line 7: | ||
==Classification of Recommendations== | ==Classification of Recommendations== | ||
===Class I: Benefit >>> Risk=== | |||
Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective. | |||
===Class II:=== | |||
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment. | |||
=====Class IIa: Benefit >> Risk===== | |||
Weight of evidence/opinion is in favor of usefulness/efficacy. | |||
=====Class IIb: Benefit ≥ Risk===== | |||
Usefulness/efficacy is less well established by evidence/opinion. | |||
===Class III: Risk ≥ Benefit=== | |||
Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful. | |||
Use the '''Level of Evidence''' designation to indicate the strength of the data associated with that recommendation. | =====Class III: No Benefit===== | ||
Is not recommended, not indicated, should not be performed/ administered/ other. Is not useful/beneficial/effective. | |||
=====Class III: Harm===== | |||
Potentially harmful, causes harm, associated with excess morbidity/mortality. Should not be performed/administered/other. | |||
Use the '''Level of Evidence''' designation to indicate the strength of the data associated with that recommendation. | |||
==Level of Evidence== | ==Level of Evidence== |
Revision as of 20:25, 22 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The Class designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.
Classification of Recommendations
Class I: Benefit >>> Risk
Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective.
Class II:
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.
Class IIa: Benefit >> Risk
Weight of evidence/opinion is in favor of usefulness/efficacy.
Class IIb: Benefit ≥ Risk
Usefulness/efficacy is less well established by evidence/opinion.
Class III: Risk ≥ Benefit
Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful.
Class III: No Benefit
Is not recommended, not indicated, should not be performed/ administered/ other. Is not useful/beneficial/effective.
Class III: Harm
Potentially harmful, causes harm, associated with excess morbidity/mortality. Should not be performed/administered/other.
Use the Level of Evidence designation to indicate the strength of the data associated with that recommendation.
Level of Evidence
- Level of Evidence A: Data derived from multiple randomized clinical trials or meta-analyses.
- Level of Evidence B: Data derived from a single randomized trial, or nonrandomized studies.
- Level of Evidence C: Only consensus opinion of experts,case studies, or standard-of-care.
Applying Classification of Recommendations and Level of Evidence
“ | ” |